In the trial, patients who received a once-weekly 20 mg injection of amycretin over 36 weeks saw an impressive 22% reduction ...
FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.
The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...
A new report finds half of adults in the United States could be eligible for popular weight loss drugs. KYW medical editor Dr ...
Colorado plans to start limiting insurance coverage of prescription weight-loss drugs for its roughly 40,000 state employees, a cost-cutting measure in a difficult budget year that officials say will ...
Colorado plans to limit insurance coverage for weight-loss drugs like Wegovy and Ozempic for thousands of state employees.
Intramuscular fat, contained within muscle tissue, increases the risk of serious heart disease, regardless of other risk factors, a new study suggests.
The study of GLP1R variants shows associations with cardiometabolic traits and behavioral changes, highlighting indirect effects of GLP1RA on mental health.
From Novo Holding's purchase of Catalent to BMS's Karuna acquisition, here are 10 of the most significant M&A moments of 2024.
The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...
A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.